Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Sold by Dai Ichi Life Insurance Company Ltd

Dai Ichi Life Insurance Company Ltd decreased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.9% in the second quarter, HoldingsChannel.com reports. The firm owned 51,897 shares of the pharmacy operator’s stock after selling 1,032 shares during the quarter. Dai Ichi Life Insurance Company Ltd’s holdings in Walgreens Boots Alliance were worth $2,200,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Caisse DE Depot ET Placement DU Quebec raised its holdings in shares of Walgreens Boots Alliance by 2.3% during the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,818,565 shares of the pharmacy operator’s stock valued at $677,949,000 after acquiring an additional 334,500 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Walgreens Boots Alliance by 2.4% during the first quarter. Geode Capital Management LLC now owns 11,478,627 shares of the pharmacy operator’s stock valued at $524,182,000 after acquiring an additional 271,485 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Walgreens Boots Alliance by 17.6% during the first quarter. JPMorgan Chase & Co. now owns 9,039,778 shares of the pharmacy operator’s stock valued at $413,569,000 after acquiring an additional 1,350,716 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Walgreens Boots Alliance by 3.0% during the second quarter. Bank of New York Mellon Corp now owns 7,377,295 shares of the pharmacy operator’s stock valued at $312,724,000 after acquiring an additional 217,272 shares during the last quarter. Finally, Aristotle Capital Management LLC raised its holdings in shares of Walgreens Boots Alliance by 53.2% during the first quarter. Aristotle Capital Management LLC now owns 7,289,353 shares of the pharmacy operator’s stock valued at $333,488,000 after acquiring an additional 2,529,868 shares during the last quarter. 55.96% of the stock is owned by institutional investors.

A number of brokerages have commented on WBA. Barclays reduced their target price on Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating for the company in a report on Friday, July 10th. SunTrust Banks dropped their price target on Walgreens Boots Alliance from $42.00 to $40.00 and set a “hold” rating for the company in a research report on Friday, July 10th. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Friday, May 15th. ValuEngine lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 27th. Finally, Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $49.00 to $45.00 and set an “equal weight” rating for the company in a research report on Thursday, July 2nd. Four investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $45.80.

Shares of Walgreens Boots Alliance stock opened at $36.76 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.69 and a quick ratio of 0.33. Walgreens Boots Alliance Inc has a 1 year low of $36.50 and a 1 year high of $64.50. The company has a market capitalization of $32.95 billion, a P/E ratio of 44.83, a P/E/G ratio of 1.62 and a beta of 0.43. The business has a 50 day moving average price of $40.56 and a 200 day moving average price of $43.26.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.10 by ($0.27). Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The company had revenue of $34.63 billion for the quarter, compared to analyst estimates of $34.32 billion. During the same quarter in the prior year, the firm earned $1.47 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. As a group, research analysts expect that Walgreens Boots Alliance Inc will post 4.68 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Wednesday, August 19th will be given a dividend of $0.4675 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. This represents a $1.87 annualized dividend and a dividend yield of 5.09%. The ex-dividend date of this dividend is Tuesday, August 18th. Walgreens Boots Alliance’s payout ratio is currently 31.22%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: What is a Real Estate Investment Trust (REIT)?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.